Emergent Biosolutions Inc

Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT

Emergent Biosolutions Inc (EBS) SEC filings

Emergent Biosolutions Inc (EBS) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported EBS revenue for 2025-12-31 was $742.9M. Net income was $52.6M. Revenue was down 28.8% from 2024-12-31 to 2025-12-31. EBS currently screens at market cap $416.4M. The EBS filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Emergent Biosolutions Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

Earnings & events

All events

Event insights for EBS — what management said, what changed, and why it matters.

Recent filings

These filings as JSON? API free 100/day

EBS SEC filings FAQ

What is the latest EBS SEC filing?

The latest cached Emergent Biosolutions Inc (EBS) filing on this page is 8-K · Oct 16, 2026. Filings: https://lician.com/sec/ebs

What is the latest EBS filing accession number?

The latest cached Emergent Biosolutions Inc (EBS) accession number on this page is 0001367644-26-000098. Filing: https://lician.com/sec/ebs/0001367644-26-000098

Which item codes are on the latest EBS filing?

Cached item codes on the latest Emergent Biosolutions Inc (EBS) 8-K are 5.02, 9.01.

How many EBS SEC filings are listed on this page?

This page lists 5 cached Emergent Biosolutions Inc (EBS) SEC filings. Filings: https://lician.com/sec/ebs

What events are listed on the EBS SEC page?

Cached event headlines on this Emergent Biosolutions Inc (EBS) SEC page: "EBS earnings". Events: https://lician.com/sec/ebs

What are EBS's latest revenue and net income?

Latest cached Emergent Biosolutions Inc (EBS) revenue for Dec 31, 2025 was $742.9M. Net income was $52.6M. Statements: https://lician.com/financials/ebs